OPKO Health Gross Profit 2010-2025 | OPK

OPKO Health gross profit from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
OPKO Health Annual Gross Profit
(Millions of US $)
2024 $219
2023 $318
2022 $288
2021 $582
2020 $541
2019 $329
2018 $386
2017 $346
2016 $506
2015 $256
2014 $43
2013 $48
2012 $19
2011 $11
2010 $15
2009 $2
OPKO Health Quarterly Gross Profit
(Millions of US $)
2025-03-31 $43
2024-12-31 $85
2024-09-30 $40
2024-06-30 $52
2024-03-31 $42
2023-12-31 $45
2023-09-30 $48
2023-06-30 $126
2023-03-31 $99
2022-12-31 $56
2022-09-30 $31
2022-06-30 $116
2022-03-31 $85
2021-12-31 $109
2021-09-30 $142
2021-06-30 $150
2021-03-31 $182
2020-12-31 $176
2020-09-30 $155
2020-06-30 $139
2020-03-31 $71
2019-12-31 $82
2019-09-30 $87
2019-06-30 $82
2019-03-31 $78
2018-12-31 $72
2018-09-30 $99
2018-06-30 $114
2018-03-31 $101
2017-12-31 $4
2017-09-30 $95
2017-06-30 $135
2017-03-31 $112
2016-12-31 $12
2016-09-30 $147
2016-06-30 $204
2016-03-31 $144
2015-12-31 $133
2015-09-30 $76
2015-06-30 $28
2015-03-31 $20
2014-12-31 $14
2014-09-30 $9
2014-06-30 $11
2014-03-31 $10
2013-12-31 $9
2013-09-30 $9
2013-06-30 $11
2013-03-31 $20
2012-12-31 $7
2012-09-30 $4
2012-06-30 $4
2012-03-31 $4
2011-12-31 $2
2011-09-30 $3
2011-06-30 $4
2011-03-31 $3
2010-12-31 $8
2010-09-30 $2
2010-06-30 $3
2010-03-31 $2
2009-12-31 $0
2009-09-30 $0
2009-06-30 $1
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.999B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $193.381B 84.70
Thermo Fisher Scientific (TMO) United States $148.604B 17.98
Edwards Lifesciences (EW) United States $43.989B 28.84
Alcon (ALC) Switzerland $42.676B 28.84
IDEXX Laboratories (IDXX) United States $40.337B 46.36
DexCom (DXCM) United States $33.137B 51.22
STERIS (STE) Ireland $23.875B 26.33
IQVIA Holdings (IQV) United States $23.701B 13.27
Mettler-Toledo (MTD) United States $23.155B 27.54
Waters (WAT) United States $20.612B 29.08
SONOVA HOLDING (SONVY) Switzerland $19.146B 0.00
Hologic (HOLX) United States $12.096B 13.14
Sysmex ADR (SSMXY) Japan $10.632B 30.16
Penumbra (PEN) United States $10.399B 81.62
Masimo (MASI) United States $8.140B 30.03
Globus Medical (GMED) United States $7.982B 19.02
Glaukos (GKOS) United States $5.487B 0.00
Teleflex (TFX) United States $5.337B 8.81
TransMedics (TMDX) United States $4.203B 91.36
Integer Holdings (ITGR) United States $4.128B 21.63
PROCEPT BioRobotics (PRCT) United States $3.175B 0.00
LivaNova (LIVN) United Kingdom $2.284B 13.60
Veracyte (VCYT) United States $2.127B 29.85
Nihon Kohden (NHNKY) Japan $1.943B 22.28
Elekta AB (EKTAY) Sweden $1.922B 17.28
Alphatec Holdings (ATEC) United States $1.820B 0.00
Tandem Diabetes Care (TNDM) United States $1.380B 0.00
Artivion (AORT) United States $1.222B 114.44
Pulse Biosciences (PLSE) United States $1.136B 0.00
Integra LifeSciences Holdings (IART) United States $0.956B 5.08
SiBone (SIBN) United States $0.783B 0.00
IRadimed (IRMD) United States $0.650B 32.96
RxSight (RXST) United States $0.637B 0.00
Beta Bionics (BBNX) United States $0.626B 0.00
Mesa Laboratories (MLAB) United States $0.597B 13.05
NeuroPace (NPCE) United States $0.580B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.569B 8.86
Delcath Systems (DCTH) United States $0.561B 0.00
OrthoPediatrics (KIDS) United States $0.506B 0.00
AxoGen (AXGN) United States $0.504B 0.00
Semler Scientific (SMLR) United States $0.494B 13.15
ORTHOFIX MEDICAL INC (OFIX) United States $0.435B 0.00
AngioDynamics (ANGO) United States $0.384B 0.00
Treace Medical Concepts (TMCI) United States $0.370B 0.00
ClearPoint Neuro (CLPT) United States $0.333B 0.00
Pacific Biosciences Of California (PACB) United States $0.277B 0.00
Neuronetics (STIM) United States $0.263B 0.00
Tactile Systems Technology (TCMD) United States $0.219B 13.27
Alpha Tau Medical (DRTS) Israel $0.211B 0.00
Inogen (INGN) United States $0.176B 0.00
Spectral Diagnostics (EDTXF) Canada $0.175B 0.00
CVRx (CVRX) United States $0.174B 0.00
908 Devices (MASS) United States $0.172B 0.00
Lucid Diagnostics (LUCD) United States $0.172B 0.00
Sight Sciences (SGHT) United States $0.165B 0.00
Accuray (ARAY) United States $0.162B 0.00
LENSAR (LNSR) United States $0.160B 0.00
Biosig Technologies (BSGM) United States $0.144B 0.00
Rapid Micro Biosystems (RPID) United States $0.143B 0.00
Anteris Technologies Global (AVR) Australia $0.131B 0.00
Atossa Genetics (ATOS) United States $0.107B 0.00
Microbot Medical (MBOT) United States $0.097B 0.00
Monogram Orthopaedics (MGRM) United States $0.093B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
Sensus Healthcare (SRTS) United States $0.077B 46.90
EDAP TMS S.A (EDAP) France $0.066B 0.00
EnVVeno Medical (NVNO) United States $0.059B 0.00
Covalon Technologies (CVALF) Canada $0.055B 16.67
Hyperfine (HYPR) United States $0.042B 0.00
Vicarious Surgical (RBOT) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.037B 0.00
Envoy Medical (COCH) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Baird Medical Investment Holdings (BDMD) $0.032B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Adagio Medical Holdings (ADGM) United States $0.018B 0.00
NexGel (NXGL) United States $0.017B 0.00
PAVmed (PAVM) United States $0.011B 0.00
WORK Medical Technology Group (WOK) China $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.006B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.58
Spinal Elements Holdings (SPEL) United States $0.000B 0.00